We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+17.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.66B
AUM Growth
+$537M
Cap. Flow
-$23.3M
Cap. Flow %
-0.5%
Top 10 Hldgs %
6.44%
Holding
1,468
New
106
Increased
604
Reduced
314
Closed
113

Top Buys

Rank Stock Value
1
XRX icon
Xerox
XRX
+$14.1M
2
DAN icon
Dana Inc
DAN
+$12.5M
3
OPEN icon
Opendoor
OPEN
+$10.6M
4
CSCO icon
Cisco
CSCO
+$7.51M
5
JBLU icon
JetBlue
JBLU
+$7.32M

Sector Composition

Rank Sector Weight
1 Financials 26.7%
2 Consumer Discretionary 12.75%
3 Industrials 12.29%
4 Technology 10.9%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOWL icon
1051
Werewolf Therapeutics
HOWL
$19.3M
$328K 0.01%
85,086
-10,425
-11% -$26.6K
AIOT
1052
PowerFleet Inc
AIOT
$592M
$327K 0.01%
95,700
APT icon
1053
Alpha Pro Tech
APT
$53.1M
$327K 0.01%
61,800
TECX
1054
Tectonic Therapeutic
TECX
$606M
$326K 0.01%
19,999
+7,716
+63% +$132K
SCWX
1055
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$319K 0.01%
43,180
ENZ
1056
DELISTED
Enzo Biochem, Inc.
ENZ
$316K 0.01%
227,100
RNAC icon
1057
Cartesian Therapeutics
RNAC
$268M
$314K 0.01%
15,193
SLDB icon
1058
Solid Biosciences
SLDB
$900M
$313K 0.01%
51,057
+15,000
+42% +$48K
SYRS
1059
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$308K 0.01%
39,500
RLYB icon
1060
Rallybio
RLYB
$85.8M
$307K 0.01%
16,063
+5,813
+57% +$142K
FOSL icon
1061
Fossil Group
FOSL
$318M
$305K 0.01%
209,000
+69,000
+49% +$101K
HHS icon
1062
Harte-Hanks
HHS
$302K 0.01%
44,546
+4,100
+10% +$27.3K
TALK icon
1063
Talkspace
TALK
$874M
$297K 0.01%
116,800
-111,000
-49% -$224K
ASYS icon
1064
Amtech Systems
ASYS
$272M
$292K 0.01%
69,600
GIFI
1065
DELISTED
Gulf Island Fabrication
GIFI
$291K 0.01%
67,148
DNMR
1066
DELISTED
Danimer Scientific, Inc.
DNMR
$291K 0.01%
7,125
+5,625
+375% +$306K
RMBI icon
1067
Richmond Mutual Bancorp
RMBI
$254M
$288K 0.01%
25,000
IMRX icon
1068
Immuneering
IMRX
$292M
$287K 0.01%
39,049
AIRT icon
1069
Air T
AIRT
$86.1M
$285K 0.01%
17,250
TRVI icon
1070
Trevi Therapeutics
TRVI
$2.64B
$283K 0.01%
211,481
+25,000
+13% +$37.9K
IMA
1071
ImageneBio Inc
IMA
$64.6M
$283K 0.01%
11,963
+2,409
+25% +$78.5K
VWOB icon
1072
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.18B
$282K 0.01%
4,429
+807
+22% +$48.6K
ZVIA icon
1073
Zevia
ZVIA
$111M
$281K 0.01%
140,000
+30,000
+27% +$60.2K
TDUP icon
1074
ThredUp
TDUP
$422M
$281K 0.01%
125,000
-75,000
-38% -$195K
CONN
1075
DELISTED
Conn's Inc.
CONN
$281K 0.01%
63,300
+33,300
+111% +$110K

Similar funds

Bridgeway Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bridgeway Capital Management held 1,468 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q4 2023 filing shows 106 new, 604 increased, 314 reduced and 113 closed positions. Its largest new stake was Xerox: 953,092 shares worth $17.5M. The largest sale was Textainer Group Holdings limited, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q4 2023 buy was Xerox: 953,092 shares worth $17.5M.
  • Bridgeway Capital Management added most to Opendoor in Q4 2023, an estimated $10.6M increase.
  • Bridgeway Capital Management's biggest Q4 2023 reduction was Textainer Group Holdings limited, cutting an estimated $19.1M.
  • Bridgeway Capital Management fully exited VERITIV CORPORATION in Q4 2023, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.66B portfolio in Q4 2023.
  • Bridgeway Capital Management opened 106 new positions and closed 113 in Q4 2023.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.